RxDoctor Payments Data

Karen Kinsley, MD

Family Medicine · Elmhurst, ILNPI 1851740161

Payments from drug & device makers

$1,567in general payments, 2019–2025

Across 29 payments — averaging $54.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$356
  • Johnson & Johnson$264
  • Boehringer Ingelheim$248
  • Lilly USA, LLC$203
  • Exact Sciences$154
  • Astellas Pharma US Inc$120
  • plus $223 from 5 others

What the payments were for

  • Food & beverage$1,567100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,567 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$56,959
Medicare patients
152
Services billed
551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin17$28,442
EliquisApixaban16$26,036
OzempicSemaglutide21$22,883
MounjaroTirzepatide18$19,225
RybelsusSemaglutide12$14,402
XareltoRivaroxaban14$14,335
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,518
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,311
Levothyroxine Sodium147$2,128
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen90$2,072
Ventolin HfaAlbuterol Sulfate14$1,630
Atorvastatin Calcium191$1,475
Pantoprazole Sodium90$1,454
Albuterol Sulfate HfaAlbuterol Sulfate42$1,444
Bupropion XlBupropion Hcl22$1,406

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$54$37,28533 claims
Boehringer IngelheimJardiance$248$28,44217 claims
PfizerEliquis$50$26,03616 claims
Lilly USA, LLCMounjaro$203$19,22518 claims
Johnson & JohnsonXarelto$264$14,33514 claims
GSKTrelegy Ellipta$92$9,51815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Elmhurst

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →